oti Reports Second Quarter 2016 Financial Results ROSH

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
oti Reports Second Quarter 2016 Financial Results

ROSH PINA, ISRAEL--(Marketwired - Aug 10, 2016) - On Track Innovations Ltd. (oti) ( NASDAQ : OTIV ), a global provider of near field communication (NFC) and cashless payment systems, reported financial results for the second quarter ended June 30, 2016.

Q2 2016 Operational Highlights

  • Partnered with Microtronic to bring world's first open and closed loop payment solution to the global vending market
  • Formed partnerships with vending distributors to the Romanian, Netherlands and Flanders markets
  • Unattended Card Payments (UCP) selected the SATURN 6500 TRIO reader and CONNECT 3000 telemetry controller as part of its portfolio of offerings for the North American unattended market
  • Partnered with Samsung Pay and other global point-of-sale providers to accelerate adoption of mobile payments
  • Introduced PayCapsule-Flex, one of the smallest payment cards designed to turn existing products and apparel into payment devices with Internet of Things (IoT) capabilities
  • OTI PetroSmart partnered with Fuel Telematics Solutions to deliver secure mobile payment for corporate fleet vehicles
  • OTI PetroSmart received a follow-on order from Smart Applications International Ltd. for more than 500,000 MediSmart™ cards

Q2 2016 Financial Details  Total revenues increased 4% to $5.1 million from $4.9 million in the prior quarter, and decreased 6% from $5.4 million in the same year-ago period.

Gross profit was $2.66 million (52.2% of revenue) compared to $2.70 million (49.8% of revenue) in the same year-ago period.

Operating expenses decreased 30% to $3.2 million from $4.6 million in the same year-ago period.

Net loss from continuing operations totaled $639,000 or $(0.02) per share, an improvement from a net loss from continuing operations of $2.0 million or $(0.05) per share in the same year-ago period.

Net income totaled $1.3 million or $0.03 per share, an improvement from a net loss of $2.0 million or $(0.05) per share in the same year-ago period.

Adjusted EBITDA loss from continuing operations improved to $155,000 from a loss of $683,000 in the same year-ago period (see discussion about the presentation of adjusted EBITDA from continuing operations, a non-GAAP financial measure, below).

At quarter-end, cash and cash equivalents and short-term investments increased 16% to $11.2 million, compared to $9.6 million at the end of the prior quarter.

Management Commentary "Our performance in Q2 demonstrated once again the positive impact of the financial and operational initiatives we have implemented over the last four quarters," said oti CEO, Shlomi Cohen. "In addition to the sequential increase in revenue, the quarter was highlighted by several milestones, including the fourth consecutive decrease in operating expenses and third consecutive improvement in adjusted EBITDA. In fact, due to the one-time payment we received in the second quarter related to the sale of our SmartID subsidiary, Q2 marked our first GAAP profitable quarter since Q4 2013.

"These significant improvements were the result of our efficiency program, which not only reduced costs and optimized our internal processes and manufacturing practices, but also established a solid foundation for our future growth. Along that line, we continue to execute on our plan to capture market share and drive growth across our business segments, particularly retail payments. In addition to the strategic partnerships we recently formed with companies like Samsung Pay and Microtronic, we made meaningful strides in our transition to a recurring revenue business model by focusing on selling a platform that includes telemetry systems and payment processing services. This was demonstrated by our ability to secure increased orders for otiMetry from the European market, which generated recurring revenue from the telemetry systems connected to our network. This platform approach allows us to target a significantly larger addressable market, while providing an opportunity to generate high-margin recurring revenue.

"We are implementing this same platform approach in Japan, which we believe presents a six-million-unit market opportunity for our industry-leading solutions given the untapped nature of the market and nationwide shift toward cashless payments. Last month we achieved a significant milestone by receiving FeliCa certification for our new SATURN 8700 reader. In fact, we were able to quickly capitalize on our early-mover advantage by already securing a letter of intent from a multi-billion dollar Japanese retailer to purchase 10,000 FeliCa-certified readers over the next three years. Our initial success in this important market reaffirms our belief that Japan will be a major market for oti in the years to come.

"Looking ahead, we plan to build on this momentum throughout the year and into 2017. We are confident in our continued ability to further penetrate our key markets and verticals, generate recurring revenue, and leverage our relatively fixed cost structure. We believe we have the right business model, partners, products, and team in place to further establish oti as the growing leader in cashless payment solutions globally."

Conference Call oti will hold a conference call today (August 10, 2016) at 10:30 a.m. Eastern time to discuss these results. oti CEO Shlomi Cohen and CFO Yishay Curelaru will host the presentation, followed by a question and answer period.

Date: Wednesday, August 10, 2016 Time: 10:30 a.m. Eastern time U.S. dial-in: 877-407-0784 International dial-in: 201-689-8560

The conference call will be broadcast simultaneously and available for replay via the investor relations section of the company's website here , the content of which is not part of this press release.

Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios at 949-574-3860.

A replay of the call will be available after 1:30 p.m. Eastern time through September 10, 2016.

U.S. replay dial-in: 877-870-5176 International replay dial-in: 858-384-5517 Replay ID: 13642381

Use of Non-GAAP Financial Information This press release contains certain non-GAAP measures, namely, adjusted EBITDA from continuing operations, or adjusted earnings from continuing operations before interest, income tax, depreciation and amortization. Adjusted EBITDA from continuing operations represents earnings before interest or financing expenses, income tax, depreciation and amortization, and further eliminates the effect of stock-based compensation expense, patent litigation and maintenance expenses and other expenses. oti believes that adjusted EBITDA from continuing operations should be considered in evaluating the company's operations since it provides a clearer indication of oti's operating results. This measure should be considered in addition to results prepared in accordance with US GAAP, but should not be considered a substitute for the US GAAP results. The non-GAAP measures included in this press release have been reconciled to the US GAAP results in the tables below. 

   
ON TRACK INNOVATIONS LTD.  
INTERIM UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENT  
The following tables reflect selected On Track Innovations Ltd. non-GAAP results reconciled to GAAP results:  
(In thousands, except share and per share data)  
   
    Three months ended June 30,     Six months ended June 30,  
    2016     2015     2016     2015  
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
                                 
                                 
  Net Income (Loss)   $ 1,349     $ (2,049 )   $ 421     $ (3,809 )
                                 
  Net income from discontinued operations     (1,988 )     -       (1,927 )     (362 )
  Financial expenses, net     67       195       171       420  
  Depreciation     312       319       620       617  
  Taxes on income     16       (16 )     32       3  
TOTAL EBITDA FROM CONTINUING OPERATIONS   $ (244 )   $ (1,551 )   $ (683 )   $ (3,131 )
                                 
Patent litigation and maintenance     11       283       28       459  
Other expenses     -       433       -       510  
Stock-based compensation     78       152       105       332  
TOTAL ADJUSTED EBITDA FROM CONTINUING OPERATIONS   $ (155 )   $ (683 )   $ (550 )   $ (1,830 )
                                 

About oti On Track Innovations Ltd. (oti) is a leader in contactless and NFC applications based on its extensive patent and IP portfolio. oti's field-proven innovations have been deployed around the world to address NFC and other cashless payment solutions, petroleum payment and management, cashless parking fee collection systems and mass transit ticketing. oti markets and supports its solutions through a global network of regional offices and alliances. For more information, visit www.otiglobal.com , the content of which is not part of this press release.

Safe Harbor for Forward-Looking Statements  This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Whenever words such as "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions are used, the company is making forward-looking statements. For example, forward-looking statements include statements regarding our intent to rollout new products and our position to capitalize on the cashless payment market. Because such statements deal with future events and are based on oti's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of oti could differ materially from those described in or implied by the statements in this press release. Forward-looking statements could be impacted by the effects of the protracted evaluation and validation periods in the U.S. and other markets for contactless payment cards, as well as oti's new and existing products and our ability to execute production on orders, as well as other risks and uncertainties, including those discussed in the "Risk Factors" section and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2015, and in subsequent filings with the Securities and Exchange Commission. Although the company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can provide no assurance that expectations will be achieved. Except as otherwise required by law, oti disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise. 

 
ON TRACK INNOVATION LTD.
INTERIM UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEET
(In thousands, except share and per share data)
 
    June 30,   December 31,
    2016   2015
Assets            
             
Current assets            
Cash and cash equivalents   $ 4,816   $ 5,450
Short-term investments     6,342     5,454
Trade receivables (net of allowance for doubtful accounts of $633 and $778 as of June 30, 2016 and December 31, 2015, respectively)     3,613     2,418
Other receivables and prepaid expenses     1,971     2,183
Inventories     2,637     3,330
             
Total current assets     19,379     18,835
             
             
Long-term restricted deposit for employees benefit     465     524
             
Severance pay deposits     328     455
             
Property, plant and equipment, net     8,153     8,668
             
Intangible assets, net     239     180
             
             
             
             
             
             
             
             
             
             
             
             
Total Assets   $ 28,564   $ 28,662
             
   
ON TRACK INNOVATION LTD.  
INTERIM UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEET  
(In thousands, except share and per share data)  
   
    June 30,     December 31,  
    2016     2015  
Liabilities and Equity                
                 
Current Liabilities                
Short-term bank credit and current maturities of long-term bank loans   $ 3,854     $ 3,815  
Trade payables     5,607       5,441  
Other current liabilities     2,643       2,724  
                 
Total current liabilities     12,104       11,980  
                 
Long-Term Liabilities                
Long-term loans, net of current maturities     1,859       2,359  
Accrued severance pay     904       1,148  
Deferred tax liability     370       352  
Total long-term liabilities     3,133       3,859  
                 
Total Liabilities     15,237       15,839  
                 
                 
Commitments and Contingencies                
                 
Equity                
Shareholders' Equity                
Ordinary shares of NIS 0.1 par value: Authorized - 50,000,000 shares as of June 30, 2016 and December 31, 2015; issued: 42,084,075 and 42,014,673 shares as of June 30, 2016 and December 31, 2015, respectively; outstanding: 40,905,376 and 40,835,974 shares as of June 30, 2016 and December 31, 2015, respectively     1,055       1,055  
Additional paid-in capital     226,030       225,925  
Treasury shares at cost - 1,178,699 shares as of June 30, 2016 and December 31, 2015     (2,000 )     (2,000 )
Accumulated other comprehensive loss     (1,106 )     (1,084 )
Accumulated deficit     (208,806 )     (209,254 )
Total Shareholder's equity     15,173       14,642  
Non-controlling interest     (1,846 )     (1,819 )
                 
Total Equity     13,327       12,823  
                 
Total Liabilities and Equity   $ 28,564     $ 28,662  
                 
   
ON TRACK INNOVATION LTD.  
INTERIM UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS  
(In thousands, except share and per share data)  
   
    Three months ended June 30,     Six months ended June 30,  
    2016     2015     2016     2015  
                                 
Revenues                        
Sales   $ 3,708     $ 4,057     $ 7,201     $ 7,654  
Licensing and transaction fees     1,381       1,359       2,765       2,737  
                                 
Total revenues     5,089       5,416       9,966       10,391  
                                 
Cost of revenues                                
Cost of sales     2,434       2,718       4,766       5,223  
Total cost of revenues     2,434       2,718       4,766       5,223  
                                 
Gross profit     2,655       2,698       5,200       5,168  
Operating expenses                                
Research and development     784       937       1,535       1,905  
Selling and marketing     1,504       1,772       3,090       3,658  
General and administrative     912       1,143       1,850       2,384  
Patent litigation and maintenance     11       283       28       459  
Other expenses     -       433       -       510  
                                 
Total operating expenses     3,211       4,568       6,503       8,916  
                                 
Operating loss from continuing operations     (556 )     (1,870 )     (1,303 )     (3,748 )
                                 
Financial expenses, net     (67 )     (195 )     (171 )     (420 )
                                 
Loss from continuing operations before taxes on income     (623 )     (2,065 )     (1,474 )     (4,168 )
                                 
Income tax     (16 )     16       (32 )     (3 )
                                 
Net loss from continuing operations     (639 )     (2,049 )     (1,506 )     (4,171 )
Net income from discontinued operations     1,988       -       1,927       362  
Net income (loss)     1,349       (2,049 )     421       (3,809 )
                                 
Net loss (income) attributable to non-controlling interest     (36 )     35       27       26  
                                 
Net income (loss) attributable to shareholders   $ 1,313     $ (2,014 )   $ 448     $ (3,783 )
                                 
Basic and diluted net gain (loss) attributable to shareholders per ordinary share                                
From continuing operations     (0.02 )     (0.05 )     (0.04 )     (0.10 )
From discontinued operations     0.05       -       0.05       0.01  
                                 
    $ 0.03     $ (0.05 )   $ 0.01     $ (0.09 )
                                 
Weighted average number of ordinary shares used in computing basic and diluted net (loss) income per ordinary share     40,896,863       40,873,680       40,885,668       40,865,089  
                                 
   
ON TRACK INNOVATION LTD.  
INTERIM UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW  
(In thousands, except share and per share data)  
   
    Six months ended June 30,  
    2016     2015  
Cash flows from continuing operating activities                
Net loss from continuing operations   $ (1,506 )   $ (4,171 )
Adjustments required to reconcile net loss to net cash used in continuing operating activities:                
Stock-based compensation related to options issued to employees     105       332  
Accrued interest and linkage differences, net     55       (42 )
Depreciation     620       617  
                 
                 
Changes in operating assets and liabilities:                
Accrued severance pay, net     (117 )     (20 )
Deferred tax, net     32       1  
(Increase) decrease in trade receivables, net     (1,097 )     482  
Decrease in other receivables and prepaid expenses     210       374  
Decrease in inventories     691       290  
Increase (decrease) in trade payables     190       (274 )
(Decrease) increase in other current liabilities     (489 )     119  
Net cash used in continuing operating activities     (1,306 )     (2,292 )
                 
Cash flows from continuing investing activities                
                 
Purchase of property and equipment, net     (139 )     (463 )
Increase in short-term investments, net     (884 )     2,163  
Investment in capitalized product costs     (98 )     (67 )
Advance payment from sale of property     396       -  
Investment in restricted deposit for employees benefit     -       (281 )
Net cash (used in) provided by continuing investing activities     (725 )     1,352  
                 
Cash flows from continuing financing activities                
Increase in short-term bank credit, net     81       809  
Proceeds from long-term bank loans     27       446  
Repayment of long-term bank loans     (538 )     (404 )
Proceeds from exercise of options     (* )     -  
                 
Net cash (used in) provided by continuing financing activities     (430 )     851  
                 
Cash flows from discontinued operations                
Net cash used in discontinued operating activities     (105 )     (25 )
Net cash provided by discontinued investing activities     1,949       387  
Total net cash provided by discontinued operations     1,844       362  
                 
Effect of exchange rate changes on cash and cash equivalents     (17 )     (164 )
                 
(Decrease) increase in cash and cash equivalents     (634 )     109  
Cash and cash equivalents at the beginning of the period     5,450       5,351  
                 
Cash and cash equivalents at the end of the period   $ 4,816     $ 5,460  
                 
                 
(*) Less than $1.                
                 

Investor Contact: Matt Glover Liolios Group, Inc. 949-574-3860 Email Contact Press Contact: Nir (Neil) Barr oti Marketing Director +972-4-686-8004 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 173

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
De La Rue plc: Key Information on Recent Trading Activities

Updated Category News Views 138

Overview of Recent Trading Activities De La Rue plc has recently made headlines through significant trading activities that reflect its status as a leading player in the security printing and cash management industry. As a key participant in financial and currency-related services, the company often finds itself at the crossroads of public interest and regulatory...

Continue Reading
Spar Nord's Strong Financial Performance in Q1 2025

Updated Category News Views 373

Spar Nord Reports Positive Q1 2025 Financial Results Profit after tax of DKK 491 million and return on equity of 14.0% Spar Nord has kicked off 2025 with a robust profit after tax of DKK 491 million, demonstrating a notable return on equity of 14.0%. While this performance marks a promising start for the year, it has been influenced by declining interest rates impacting...

Continue Reading
Latest Trends in CEO Confidence and Economic Outlook

Updated Category News Views 260

CEO Confidence Insights for Q4 2025 The Conference Board, in partnership with The Business Council, reported a slight decrease in the CEO Confidence measure, which now stands at 48 in the fourth quarter of 2025. This reflects a one-point drop from 49 during the third quarter. The readings below 50 indicate a dominantly negative sentiment among executives. In total, 130...

Continue Reading
Shift in Options Trading: Is Tesla Gaining Momentum Over Nvidia?

Updated Category News Views 301

Shift in Options Trading Dynamics The S&P 500 experienced a modest increase, climbing by around 20 basis points, while the NASDAQ 100 saw a more substantial rise, soaring by an impressive 80 basis points. A significant contributor to this market movement was none other than Tesla (NASDAQ: TSLA), which experienced a remarkable surge of about 20% in its stock price....

Continue Reading